Neurocrine Biosciences, Inc. (0K6R.L) Dividend Yield, History & Forecast

Neurocrine Biosciences, Inc. (0K6R.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $12.90B.

Loading quote...

Frequently Asked Questions about Neurocrine Biosciences, Inc. (0K6R.L)

When does Neurocrine Biosciences, Inc. pay its next dividend?
The most recent ex-dividend date was March 15, 2022.
Is Neurocrine Biosciences, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Neurocrine Biosciences, Inc. in?
Neurocrine Biosciences, Inc. (0K6R.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.
Neurocrine Biosciences, Inc. (0K6R.L) Dividend Yield, History & Forecast | Dividend Wealth